Granulocyte colony-stimulating factor in sickle cell disease

By Kaptan Kürşat   Beyan Cengiz   Ifran Ahmet  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 1108-1108

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity

By Li B.   Yang Jl   Shi Yk   He Xh   Han Xh   Zhou Sy   Liu P.   Yang S.   Zhang Cg  

Cytotherapy, Vol. 11, Iss. 3, 2009-05 ,pp. : 362-371

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

By Fitzhugh Courtney   Hsieh Matthew   Bolan Charles   Saenz Carla   Tisdale John  

Cytotherapy, Vol. 11, Iss. 4, 2009-07 ,pp. : 464-471

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy

By Han Y   Yan L   Han G.   Zhou X.   Hong L.   Yin Z.   Zhang X.   Wang S.   Wang J.   Sun A.   Liu Z.   Xie H.   Wu K.   Ding J.   Fan D.  

Cytotherapy, Vol. 10, Iss. 4, 2008-01 ,pp. : 390-396

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Granulocyte–macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation

By Eksioglu Erika Adriana   Kielbasa Johanna   Eisen Sarah   Reddy Vijay  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 888-896

Ashgate Publishing Ltd

Access to resources Recommend Favorite